{
  "success": true,
  "pagesUsed": [
    3,
    9,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    23,
    34,
    57
  ],
  "modelUsed": "gemini-2.5-pro",
  "confidence": 1.0,
  "scheduling": {
    "timings": [
      {
        "id": "timing_1",
        "name": "Screening Window",
        "type": "Between",
        "unit": "days",
        "instanceType": "Timing",
        "relativeTo": "First Dose",
        "windowLower": -28,
        "windowUpper": -2
      },
      {
        "id": "timing_2",
        "name": "Washout Period",
        "type": "Between",
        "unit": "days",
        "instanceType": "Timing",
        "relativeTo": "Last Dose",
        "windowLower": 3,
        "windowUpper": 14
      },
      {
        "id": "timing_3",
        "name": "Follow-up Visit Window",
        "type": "At",
        "unit": "days",
        "instanceType": "Timing",
        "value": 28,
        "relativeTo": "Last Dose",
        "windowLower": -2,
        "windowUpper": 2
      },
      {
        "id": "timing_4",
        "name": "CRU Discharge",
        "type": "After",
        "unit": "hours",
        "instanceType": "Timing",
        "value": 6,
        "relativeTo": "Last Dose",
        "windowLower": 6
      },
      {
        "id": "timing_5",
        "name": "PK and PD Sampling Duration",
        "type": "Within",
        "unit": "hours",
        "instanceType": "Timing",
        "value": 4,
        "relativeTo": "Last Dose",
        "windowLower": 0,
        "windowUpper": 4
      },
      {
        "id": "timing_6",
        "name": "Additional Follow-up for TE ADA",
        "type": "At",
        "unit": "days",
        "instanceType": "Timing",
        "value": 84,
        "relativeTo": "Previous Visit",
        "windowLower": -7,
        "windowUpper": 7
      },
      {
        "id": "timing_7",
        "name": "Maximum Duration of Additional Follow-up for TE ADA",
        "type": "Within",
        "unit": "year",
        "instanceType": "Timing",
        "value": 1,
        "relativeTo": "Last Dose",
        "windowLower": 0,
        "windowUpper": 365
      },
      {
        "id": "timing_8",
        "name": "Study Drug Administration after Insulin Stop",
        "type": "After",
        "unit": "minutes",
        "instanceType": "Timing",
        "value": 5,
        "windowLower": 5,
        "windowUpper": 5
      }
    ],
    "conditions": [
      {
        "id": "cond_1",
        "name": "Admission Criteria for Day 1",
        "instanceType": "Condition",
        "description": "Plasma Glucose level required for admission on Day 1 of a treatment period.",
        "text": "PG level must be 90 to 250 mg/dL on Day 1."
      },
      {
        "id": "cond_2",
        "name": "Insulin Infusion Stop Criteria",
        "instanceType": "Condition",
        "description": "Condition to stop the insulin infusion to induce hypoglycemia.",
        "text": "Bedside PG is <60 mg/dL."
      },
      {
        "id": "cond_3",
        "name": "Additional Follow-up Trigger",
        "instanceType": "Condition",
        "description": "Condition for entering the additional follow-up phase for immunogenicity.",
        "text": "Patient has treatment-emergent antidrug antibodies (TE ADA) at the follow-up/early discontinuation visit."
      },
      {
        "id": "cond_4",
        "name": "Interim Safety Review Condition for Continuation",
        "instanceType": "Condition",
        "description": "Condition for continuing dosing after the first 6 patients complete Period 2.",
        "text": "No clinically significant safety findings for treatment or study procedure are noted after the first 6 patients complete Period 2 Day 1."
      },
      {
        "id": "cond_5",
        "name": "Inadvertent Enrollment",
        "instanceType": "Condition",
        "description": "Condition where a patient did not meet enrollment criteria.",
        "text": "The sponsor or investigator identifies a patient who did not meet enrollment criteria and was inadvertently enrolled."
      },
      {
        "id": "cond_6",
        "name": "Study Termination Condition",
        "instanceType": "Condition",
        "description": "Condition for stopping the entire study based on interim safety review.",
        "text": "Study will be stopped if deemed necessary for patient safety in the opinion of the Investigator and sponsor following the review of the safety data from the first 6 patients to complete Period 2 Day 1."
      }
    ],
    "conditionAssignments": [],
    "transitionRules": [
      {
        "id": "trans_1",
        "name": "Transition to Additional Follow-up",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "fromElementId": "epoch_followup",
        "toElementId": "epoch_additional_followup",
        "text": "Triggered by positive TE ADA test at follow-up/ED visit."
      },
      {
        "id": "trans_2",
        "name": "End of Additional Follow-up",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "fromElementId": "epoch_additional_followup",
        "toElementId": "epoch_completed",
        "text": "Additional follow-up for TE ADA ends when titer returns to baseline or 1 year after the last dose, whichever comes first."
      },
      {
        "id": "trans_3",
        "name": "Discontinuation for Inadvertent Enrollment",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Patients inadvertently enrolled may be discontinued. However, they may continue if deemed medically appropriate and approved by the sponsor."
      }
    ],
    "scheduleTimelineExits": [
      {
        "id": "exit_1",
        "name": "Discontinuation due to Other Study Participation",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Patient is discontinued for enrollment in any other clinical study involving an investigational product or other incompatible medical research."
      },
      {
        "id": "exit_2",
        "name": "Discontinuation for Medical/Safety/Regulatory Reasons",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Discontinuation because participation needs to be stopped for medical, safety, regulatory, or other reasons consistent with applicable laws, regulations, and good clinical practice."
      },
      {
        "id": "exit_3",
        "name": "Discontinuation by Investigator Decision",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "The investigator decides that the patient should be discontinued from the study for any reason."
      },
      {
        "id": "exit_4",
        "name": "Discontinuation by Patient Withdrawal",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "The patient, or legal representative, requests to be withdrawn from the study."
      },
      {
        "id": "exit_5",
        "name": "Study Termination for Safety",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "The entire study may be stopped for patient safety reasons after an interim review of the first 6 patients completing Period 2."
      },
      {
        "id": "exit_6",
        "name": "Lost to Follow-up",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Patient is considered lost to follow-up if he or she repeatedly fails to return for scheduled visits and is unable to be contacted by the study site."
      },
      {
        "id": "exit_7",
        "name": "Study Completion",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "Patient has completed both treatment periods and the final follow-up visit."
      }
    ],
    "scheduledDecisionInstances": [
      {
        "id": "dec_1",
        "name": "Decision to Proceed with Admission",
        "timepointId": "pt_period_day1",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision point on Day 1 of each treatment period to admit the patient based on PG level. Admission can be rescheduled if criteria not met.",
        "conditionIds": [
          "cond_1"
        ]
      },
      {
        "id": "dec_2",
        "name": "Interim Safety Review Decision",
        "timepointId": "pt_interim_analysis_1",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision point after the first 6 patients complete Period 2 to continue dosing for the remaining patients or stop the study.",
        "conditionIds": [
          "cond_4",
          "cond_6"
        ]
      },
      {
        "id": "dec_3",
        "name": "Decision for Additional Follow-up",
        "timepointId": "pt_followup_visit",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision at the follow-up visit to initiate additional follow-up based on TE ADA results.",
        "conditionIds": [
          "cond_3"
        ]
      },
      {
        "id": "dec_4",
        "name": "Decision on Inadvertently Enrolled Patient",
        "timepointId": "pt_as_discovered",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision point upon discovery of an inadvertently enrolled patient to determine continuation or discontinuation.",
        "conditionIds": [
          "cond_5"
        ]
      }
    ],
    "summary": {
      "timingCount": 8,
      "conditionCount": 6,
      "transitionRuleCount": 3,
      "exitCount": 7
    }
  }
}